Episode summary
The median survival for pleural mesothelioma is 18 to 31 months with treatment. Katherine Keys has lived 18 years beyond her diagnosis — a span that, by any clinical measure, is extraordinarily rare and not representative of typical outcomes. In this first episode of a two-part series, host Dave Foster, Executive Director of patient advocacy at Danziger & De Llano and himself an 18-year veteran of supporting mesothelioma families, sits down with Katherine to trace her journey from the earliest warning signs through diagnosis, surgery, and the life she has built since. Katherine shares how her symptoms were initially misdiagnosed before doctors confirmed malignant pleural mesothelioma, and why she made the deliberate choice to seek out a mesothelioma specialist rather than a general oncologist. She describes the major lung surgery that removed her cancer — leaving her with one lung — and what daily life actually looks like nearly two decades later. The conversation also covers the mindset, family support, and medical team that Katherine credits with sustaining her, and she offers direct advice for newly diagnosed patients: act quickly, and find the right surgeon. Part 2, which continues Katherine’s story, releases the following week. Her case is presented here as an educational example of long-term survivorship, not as a prediction of what any individual patient can expect.
- Katherine Keys’ 18-year survival is explicitly exceptional — the median survival for pleural mesothelioma with treatment is 18 to 31 months, and her outcome is not a promise or a guarantee for any other patient.
- Katherine chose a mesothelioma specialist rather than a general oncologist after her diagnosis, a decision she and Dave both highlight as significant; disease-specific expertise matters when the cancer is as rare and aggressive as pleural mesothelioma.
- Misdiagnosis was part of Katherine’s early experience — her initial symptoms were not immediately recognized as mesothelioma, underscoring the importance of pursuing an accurate diagnosis when symptoms persist or when asbestos exposure is part of someone’s history.
- Katherine’s advice for newly diagnosed patients centers on two things: act quickly, and find the right surgeon — especially important given how much the choice of treatment center and surgical team can shape what options are available.
A full transcript of this episode is coming soon. Use the player above to listen now.
Frequently asked questions
What does the median survival statistic for pleural mesothelioma actually mean for a newly diagnosed patient?
Dave and Katherine open with the clinical context: the median survival for pleural mesothelioma is 18 to 31 months with treatment. A median means that half of patients in studies live longer than that figure and half live shorter — it describes a population, not an individual. Katherine’s 18-year survival is presented in this episode as a remarkable outlier, not a benchmark patients should expect to match. A specialist can discuss how individual factors — stage, cell type, overall health, treatment center — affect a specific patient’s situation. MesoCare’s treatment options pages can help you understand the landscape before those conversations.
Why is seeking a mesothelioma specialist rather than a general oncologist such a consistent recommendation?
Katherine’s experience points directly to this: she sought out a specialist rather than staying with a general oncologist after her diagnosis was confirmed. Pleural mesothelioma is rare, the surgical approaches are technically demanding, and the treatment protocols differ meaningfully from more common cancers. Specialists at high-volume mesothelioma centers see more cases and have more experience with the full range of current options. This episode presents Katherine’s choice as educational — decisions about where to seek care belong to the patient and their family, ideally informed by a consultation with a mesothelioma-experienced team.
How common is misdiagnosis with pleural mesothelioma, and what should patients know?
Katherine’s symptoms were initially misdiagnosed before doctors confirmed malignant pleural mesothelioma — an experience that is not unusual with this disease. Because mesothelioma is rare and its early symptoms (shortness of breath, chest pain, fluid around the lung) can resemble other conditions, a definitive diagnosis often requires imaging, biopsy, and pathology review by someone experienced with the disease. If symptoms persist or if there is a known history of asbestos exposure, pursuing further evaluation and a second opinion is a reasonable step. This episode is educational; a physician familiar with mesothelioma can guide the diagnostic process.
What does life look like after major lung surgery for pleural mesothelioma?
Katherine had surgery that removed her cancer along with one lung, and this episode addresses what daily life looks like 18 years later with a single lung. Dave and Katherine discuss the practical and personal realities of long-term survivorship, including the role of mindset, family support, and her ongoing relationship with her medical team. Her account is one person’s lived experience and is shared here to inform and encourage — it is not a predictor of outcomes for other patients. MesoCare’s treatment innovations pages provide broader context on the surgical options and what recovery and long-term monitoring can involve.
What is Katherine Keys’ core advice for someone who has just been diagnosed with pleural mesothelioma?
Based on what Katherine shares in this episode, her guidance comes down to two priorities: act quickly, and find the right surgeon. The urgency reflects the aggressive nature of pleural mesothelioma, where delays in diagnosis or in connecting with an experienced specialist can affect which treatment paths remain available. Finding the right surgeon points back to the value of mesothelioma-specific expertise. Katherine offers this from her own 18-year journey as education and encouragement — individual medical decisions should be made in consultation with qualified specialists.
Related episodes
- From Terminal Prognosis To Purpose: Katherine Keyes On Life After Mesothelioma
- From ICU To Independence: A Mesothelioma Survivor’s Road Back
- A Patient’s Journey Through ICU, Recovery, And The Power Of Honest Doctors
- They Called Her Family to Say Goodbye: Katherine Keys’ Mesothelioma Surgery and 18-Year Survival (Part 3)
- 18 Years After Lung Removal: Katherine Keys’ Record-Breaking Mesothelioma Survival Story (Part 2)
Hosts: David Foster & Anna Jackson (Patient Advocates).
MESO: The Mesothelioma Podcast is produced by MesoCare.org and sponsored by Danziger & De Llano. This episode is educational and is not medical or legal advice.
Medically reviewed by Marcelo C. DaSilva, MD, FACS, FICS — Thoracic Surgeon, Medical Director of Thoracic Surgery, AdventHealth Cancer Institute (last reviewed 2026-06-15).